SAN FRANCISCO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Fincom Investment Partners discusses Elixinol Global Ltd.'s (EXL:ASX; ELLXF:OTCQX) Q4 earnings, and the hemp/CBD field.
Company mentioned: Elixinol Global Ltd.
Elixinol reported quarterly (Q4) revenue at US$8.57 million, up a very strong 14% over Q3. Full year revenue growth was up 121% from December 2017.
We will have further analyst when the full earnings become available the end of February. Some Australian stocks pre-release a short "cash flow" number, before full earnings, offering a glimpse at critically important top-line sales.
Our takeaway: Robust growth continues. Elixinol is heavily investing in materials and production capacity. We expect strong growth continues in 2019, and we project upcoming Q4 earnings will confirm: Elixinol is the fastest growing hemp/CBD company.
Scientific case for CBD continues to grow
We have long proposed the ultimate CBD market (cannabidiol, a non-intoxicant) is much larger, and better, than cannabis. We believe CBD will become a health standard, available in a variety of OTC forms, and routinely carried by mass retailers. The OTC market for pain relief, stress and sleeping issues alone is massive, and CBD is a near-ideal fit.
In addition, scientific evidence for CBD continues to grow. One recent study published in the April 2019 Cancer Letter concluded, "Taken together, the results obtained in this study re-demonstrated the effects of CBD treatment in vivo, thus confirming its role as a novel, reliable anti-cancer drug."
The growing weight of accumulated evidence supports our thesis whereby millions of consumers will add a daily regimen of CBD. The OTC option allows easy access. We believe there are more millions interested in improving their health.
Continue reading this article: Is Elixinol the Fastest Growing Hemp/CBD Producer?
About Streetwise Reports
Streetwise Reports shares investment ideas in many sectors. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
DISCLOSURE:
The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
Fincom Investment Partners owns shares of the following companies mentioned in this article: Elixinol. Fincom Investment Partners currently has a consulting relationship with Elixinol.
The full disclosure is provided at the article's end: Is Elixinol the Fastest Growing Hemp/CBD Producer?